Resultados de la búsqueda - Portal de Modelos de Datos Médicos (MDM-Portal)

Pre-Study Breast Cancer SWOG S0307 NCT00127205

- 26/8/15 - 1 formulario, 10 itemgroups, 46 items, 1 idioma

Itemgroups: Administrative documentation, DISEASE DESCRIPTION, LABORATORY VALUES, CONSENT FOR SUBMISSION AND BANKING, PATIENT CHARACTERISTICS, DISEASE DESCRIPTION, TREATMENT WITH STATINS, PATIENT PREFERENCE, PRIOR TREATMENT RELATED TO THIS CANCER, SYSTEMIC TREATMENT FOR THIS CANCER

SOUTHWEST ONCOLOGY GROUP S0307 PRESTUDY FORM Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast SOUTHWEST ONCOLOGY GROUP S0307 PRESTUDY FORM Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DEA0B902-CDD3-54E6-E034-0003BA12F5E7

Breast Cancer NCT00070564 Pre-Study - SOUTHWEST ONCOLOGY GROUP S0221 BREAST CANCER PRESTUDY FORM - 2046547v3.0 - SOUTHWEST ONCOLOGY GROUP S0221 BREAST CANCER PRESTUDY FORM

- 9/1/15 - 1 formulario, 6 itemgroups, 61 items, 1 idioma

Itemgroups: Header, PATIENT CHARACTERISTICS, DISEASE DESCRIPTION, LABORATORY VALUES, PRIOR TREATMENT RELATED TO THIS CANCER, Comments Module

SOUTHWEST ONCOLOGY GROUP S0221 BREAST CANCER PRESTUDY FORM Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A6788C86-182E-5088-E034-0003BA0B1A09

Breast Cancer NCT01272037 Pre-Study - S1007 Prestudy Form - Randomized Study (6230) - 3141162v1.0 - S1007 Prestudy Form - Randomized Study (6230)

- 9/1/15 - 1 formulario, 3 itemgroups, 18 items, 1 idioma

Itemgroups: Header Module, PATIENT AND DISEASE DESCRIPTION, Comments

S1007 Prestudy Form - Randomized Study (6230) Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=90DE259F-A7AB-E9EB-E040-BB89AD436D98

Breast Cancer NCT01272037 Pre-Study - S1007 Prestudy Form (45282) - 3141026v1.0 - S1007 Prestudy Form (45282)

- 9/1/15 - 1 formulario, 5 itemgroups, 40 items, 1 idioma

Itemgroups: Header Module, PATIENT AND DISEASE DESCRIPTION, ADDITIONAL PRESTUDY DATA, PRIOR TREATMENT RELATED TO THIS CANCER, Comments

S1007 Prestudy Form (45282) Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=90DB6C43-AEA1-137D-E040-BB89AD432116

Breast Cancer NCT01101438 Pre-Study - NCIC MA.32 Baseline Report - 3027459v1.0 - NCIC MA.32 Baseline Report

- 9/1/15 - 1 formulario, 13 itemgroups, 54 items, 1 idioma

Itemgroups: TOBACCO SMOKING HISTORY - BASELINE, ALCOHOL CONSUMPTION - QUESTION, BILATERAL BREAST CARCINOMA - QUESTION, BILATERAL BREAST CARCINOMA, BASELINE ADVERSE EVENTS - QUESTION, BASELINE ADVERSE EVENTS, CARDIOVASCULAR HISTORY - QUESTION, CARDIOVASCULAR HISTORY, BASELINE CONCOMITANT MEDICATIONS, ADJUVANT RADIATION THERAPY, SYSTEMIC THERAPY, MAJOR MEDICAL PROBLEMS AT BASELINE, OTHER CLINICAL TRIAL PARTICIPATION

NCIC MA.32 Baseline Report A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=81E21D11-128C-1198-E040-BB89AD434372

Breast Cancer SWOG baseline tumor assessment NCT00075764 - BASELINE TUMOR ASSESSMENT Breast cancer SWOG S0226 NCT00075764

- 25/3/15 - 1 formulario, 4 itemgroups, 20 items, 1 idioma

Itemgroups: Header, TARGET LESIONS, NON-TARGET DISEASE, Other tests

SOUTHWEST ONCOLOGY GROUP BASELINE TUMOR ASSESSMENT FORM (S0226) S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer NCT00075764 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C322202A-32BF-25B7-E034-0003BA12F5E7

Breast Cancer NCT00382018 Pre-Study - SOUTHWEST ONCOLOGY GROUP S0500 Prestudy Form - 2436725v1.0 - SOUTHWEST ONCOLOGY GROUP S0500 Prestudy Form

- 9/1/15 - 1 formulario, 6 itemgroups, 37 items, 1 idioma

Itemgroups: Header, PATIENT CHARACTERISTICS, MENOPAUSAL STATUS, DISEASE DESCRIPTION, PRIOR TREATMENT RELATED TO THIS CANCER, Comments

SOUTHWEST ONCOLOGY GROUP S0500 Prestudy Form Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=07D022D9-F34F-20A8-E044-0003BA3F9857

Breast Cancer NCT00103233 Pre-Study - SOUTHWEST ONCOLOGY GROUP Prestudy Form (S0347) - 2412719v1.0 - SOUTHWEST ONCOLOGY GROUP Prestudy Form (S0347)

- 9/1/15 - 1 formulario, 6 itemgroups, 36 items, 1 idioma

Itemgroups: Header, PATIENT CHARACTERISTICS, MENOPAUSAL STATUS, DISEASE DESCRIPTION, PRIOR TREATMENT RELATED TO THIS CANCER, Comments

SOUTHWEST ONCOLOGY GROUP Prestudy Form (S0347) Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=01ECF016-02E2-1026-E044-0003BA3F9857

Breast Cancer NCT00068601 Pre-Study - Southwest Oncology Group Ovarian Function Assessment (S0230) - 2170708v3.0 - Southwest Oncology Group Ovarian Function Assessment (S0230)

- 9/1/15 - 1 formulario, 3 itemgroups, 25 items, 1 idioma

Itemgroups: Menstrual cycle, Laboratory Test, CCRR MODULE

Southwest Oncology Group Ovarian Function Assessment (S0230) Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BEA6A9CC-6D74-0D93-E034-0003BA12F5E7

Breast Cancer NCT00068601 Pre-Study - Southwest Oncology Group BASELINE ASSESSMENT FORM (S0230) - 2170664v3.0 - Southwest Oncology Group BASELINE ASSESSMENT FORM (S0230)

- 9/1/15 - 1 formulario, 2 itemgroups, 14 items, 1 idioma

Itemgroups: BASELINE CONDITIONS, CCRR MODULE

Southwest Oncology Group BASELINE ASSESSMENT FORM (S0230) Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BEA4E960-6745-0470-E034-0003BA12F5E7

Breast Cancer NCT00659373 Pre-Study - Prior Treatment History Form (Form 24-H) - 2074666v3.0 - Prior Treatment History Form (Form 24-H)

- 9/1/15 - 1 formulario, 3 itemgroups, 25 items, 1 idioma

Itemgroups: BEFORE DIAGNOSIS: CHEMOPREVENTION FOR BREAST CANCER, PRIOR CHEMOTHERAPY REGIMEN FOR BREAST CANCER, CCRR MODULE

Prior Treatment History Form (Form 24-H) Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG-2402 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B1274765-836E-53AF-E034-0003BA12F5E7

Breast Cancer NCT00513292 Pre-Study - Z1041: Tumor Measurement Report Baseline (TMR-B) - 2533540v1.0 - Z1041: Tumor Measurement Report Baseline (TMR-B)

- 9/1/15 - 1 formulario, 5 itemgroups, 24 items, 1 idioma

Itemgroups: Header Module, Breast Target Lesions, Axilla Target Lesions, Non-Target Lesions, Footer

Z1041: Tumor Measurement Report Baseline (TMR-B) Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=21155A6B-93AC-0F34-E044-0003BA3F9857

Palabras clave

Tabla de contenido

Modelos de datos seleccionados